Europe Specialty Generics Market Report by Route of Administration (Injectables, Oral, and Others), Indication (Oncology, Autoimmune Diseases, Infectious Diseases, and Others), Distributional Channel (Retail Pharmacies, Specialty Pharmacies, Hospital Pharmacies), and Region 2025-2033

February 2025 | 140 pages | ID: E0C50C30BA89EN
IMARC Group

Abstracts

The Europe specialty generics market size reached USD 21.5 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 42.0 Billion by 2033, exhibiting a growth rate (CAGR) of 7.34% during 2025-2033. The increasing prevalence of chronic diseases, rising demand for affordable medicines, and implementation of favorable regulatory guidelines are some of the key factors driving the market.

Specialty generics refer to complex, difficult-to-produce medications that are created as a lower-cost alternative to brand-name drugs. These drugs are generally used to treat chronic conditions and diseases that require long-term therapy, such as cancer, autoimmune disorders, and human immunodeficiency virus (HIV). Specialty generics should be identical in both chemical structure and therapeutic effect to the brand-name drug it is intended to replace. The production of these drugs requires a high level of expertise and sophisticated technology to ensure quality control and consistency. Specialty generics are composed of the same active ingredient as the brand-name drug but may differ in other components, such as excipients, fillers, and binders. Currently, there are two types of product variants, such as biosimilars and complex generics. Biosimilars are drugs that are similar to biologic drugs, whereas complex generics are generic versions of drugs that are chemically and structurally complex.

Europe Specialty Generics Market Trends:

Europe specialty generics market is primarily boosted by the growing geriatric population, increasing prevalence of chronic diseases, and the rising demand for affordable medicines. Additionally, the implementation of favorable regulatory guidelines by the European Medicines Agency (EMA) and the increasing adoption of biosimilars are boosting the market growth. Apart from this, several manufacturers are developing cost-effective biosimilars that offer similar efficacy and safety as branded drugs, which is providing an impetus to the market growth. Furthermore, burgeoning investments by leading pharmaceutical companies in research and development (R&D) activities to develop innovative drugs and the rising awareness about the benefits of specialty generic drugs are providing a considerable thrust to the market growth. Moreover, the integration of robotics and artificial intelligence (AI) in the manufacturing process to enable automation, reduce manual labor, maintain product quality, and enhance overall efficiency is positively influencing the market growth. Besides this, the increasing focus on expanding the product portfolio by key players, the growing demand for personalized medicine, the surging adoption of e-prescriptions, the increasing consumer awareness and acceptance of specialty generics, rising healthcare expenditure, extensive research and development (R&D) activities, and the development of novel drug delivery technologies are accelerating the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the Europe specialty generics market report, along with forecasts at the regional and country level from 2025-2033. Our report has categorized the market based on route of administration, indication and distribution channel.

Route of Administration Insights:

• Injectables
• Oral
• Others

The report has provided a detailed breakup and analysis of the Europe specialty generics market based on the route of administration. This includes injectables, oral, and others. According to the report, the injectables segment dominates the market.

Indication Insights:

• Oncology
• Autoimmune Diseases
• Infectious Diseases
• Others

The report has provided a detailed breakup and analysis of the Europe specialty generics market based on the indication. This includes oncology, autoimmune diseases, infectious diseases, and others. According to the report, the oncology segment dominates the market.

Distributional Channel Insights:

• Retail Pharmacies
• Specialty Pharmacies
• Hospital Pharmacies

The report has provided a detailed breakup and analysis of the Europe specialty generics market based on the distributional channel. This includes retail pharmacies, specialty pharmacies, and hospital pharmacies. According to the report, the retail pharmacies segment holds the largest market share.

Regional Insights:

• Italy
• Germany
• France
• United Kingdom
• Spain
• Rest of Europe

The report has also provided a comprehensive analysis of all the major regional markets, which include. Italy, Germany, France, the United Kingdom, Spain, and the Rest of Europe. As per the report, Italy dominates the market. Some of the factors accelerating the Italy specialty generics market include the surging awareness regarding the advantages of specialty generics, inflating consumer per capita income, and the growing prevalence of chronic diseases.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the Europe specialty generics market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. The leading players in the European specialty generics industry have also been examined in the report.

Key Questions Answered in This Report

1.What was the size of the Europe specialty generics market in 2024?

2.What is the expected growth rate of the Europe specialty generics market during 2025-2033?

3.What are the key factors driving the Europe specialty generics market?

4.What has been the impact of COVID-19 on the Europe specialty generics market?

5.What is the breakup of the Europe specialty generics market based on the route of administration?

6.What is the breakup of the Europe specialty generics market based on the indication?

7.What is the breakup of the Europe specialty generics market based on the distribution channel?

8.What are the key regions in the Europe specialty generics market?

Contents

?1 Preface

2 SCOPE AND METHODOLOGY

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
  2.3.1 Primary Sources
  2.3.2 Secondary Sources
2.4 Market Estimation
  2.4.1 Bottom-Up Approach
  2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 EXECUTIVE SUMMARY

4 EUROPE SPECIALTY GENERICS MARKET: INTRODUCTION

5 WHY ARE SPECIALTY GENERICS SO LUCRATIVE?

6 EUROPE SPECIALTY GENERICS MARKET

6.1 Market Overview
6.2 Market Performance
6.3 Impact of COVID-19
6.4 Market Breakup by Route of Administration
6.5 Market Breakup by Indication
6.6 Market Breakup by Distribution Channel
6.7 Market Breakup by Region
6.8 Market Forecast
6.9 SWOT Analysis
  6.9.1 Overview
  6.9.2 Strengths
  6.9.3 Weaknesses
  6.9.4 Opportunities
  6.9.5 Threats
6.10 Value Chain Analysis
6.11 Porters Five Forces Analysis
  6.11.1 Overview
  6.11.2 Bargaining Power of Buyers
  6.11.3 Bargaining Power of Suppliers
  6.11.4 Degree of Competition
  6.11.5 Threat of New Entrants
  6.11.6 Threat of Substitutes
6.12 Key Market Drivers and Success Factors

7 MARKET BREAKUP BY ROUTE OF ADMINISTRATION

7.1 Injectable
  7.1.1 Market Trends
  7.1.2 Market Forecast
7.2 Oral
  7.2.1 Market Trends
  7.2.2 Market Forecast
7.3 Others
  7.3.1 Market Trends
  7.3.2 Market Forecast

8 MARKET BREAKUP BY INDICATION

8.1 Oncology
  8.1.1 Market Trends
  8.1.2 Market Forecast
8.2 Autoimmune Diseases
  8.2.1 Market Trends
  8.2.2 Market Forecast
8.3 Infectious Diseases
  8.3.1 Market Trends
  8.3.2 Market Forecast
8.4 Others
  8.4.1 Market Trends
  8.4.2 Market Forecast

9 MARKET BREAKUP BY DISTRIBUTION CHANNEL

9.1 Retail Pharmacies
  9.1.1 Market Trends
  9.1.2 Market Forecast
9.2 Specialty Pharmacies
  9.2.1 Market Trends
  9.2.2 Market Forecast
9.3 Hospital Pharmacies
  9.3.1 Market Trends
  9.3.2 Market Forecast

10 MARKET BREAKUP BY REGION

10.1 Germany
  10.1.1 Market Trends
  10.1.2 Market Forecast
10.2 France
  10.2.1 Market Trends
  10.2.2 Market Forecast
10.3 United Kingdom
  10.3.1 Market Overview
  10.3.2 Market Performance
10.4 Spain
  10.4.1 Market Performance
  10.4.2 Market Forecast
10.5 Others
  10.5.1 Market Trends
  10.5.2 Market Forecast

11 COMPETITIVE LANDSCAPE

11.1 Market Structure
11.2 Key Players

List Of Tables

LIST OF TABLES

Table 1: Europe: Specialty Generics Market: Key Industry Highlights, 2024 and 2033
Table 2: Europe: Specialty Generics Market Forecast: Breakup by Route of Administration (in Billion USD), 2025-2033
Table 3: Europe: Specialty Generics Market Forecast: Breakup by Indication (in Billion USD), 2025-2033
Table 4: Europe: Specialty Generics Market Forecast: Breakup by Distribution Channel (in Billion USD), 2025-2033
Table 5: Europe: Specialty Generics Market Forecast: Breakup by Region (in Billion USD), 2025-2033
Table 6: Europe: Specialty Generics Market Structure
Table 7: Europe: Specialty Generics Market: Key Players

List Of Figures

LIST OF FIGURES

Figure 1: Europe: Specialty Generics Market: Sales Value (in Billion USD), 2019-2024
Figure 2: Europe: Specialty Generics Market: Breakup by Route of Administration (in %), 2024
Figure 3: Europe: Specialty Generics Market: Breakup by Indication (in %), 2024
Figure 4: Europe: Specialty Generics Market: Breakup by Distribution Channel (in %), 2024
Figure 5: Europe: Specialty Generics Market: Breakup by Region (in %), 2024
Figure 6: Europe: Specialty Generics Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 7: Europe: Specialty Generics Industry: SWOT Analysis
Figure 8: Europe: Specialty Generics Industry: Value Chain Analysis
Figure 9: Europe: Specialty Generics Industry: Porter’s Five Forces Analysis
Figure 10: Europe: Specialty Generics Market (Administration through Injectables): Sales Value (in Billion USD), 2019 & 2024
Figure 11: Europe: Specialty Generics Market (Administration through Injectables) Forecast: Sales Value (in Billion USD), 2025-2033
Figure 12: Europe: Specialty Generics Market (Oral Administration): Sales Value (in Billion USD), 2019 & 2024
Figure 13: Europe: Specialty Generics Market (Oral Administration) Forecast: Sales Value (in Billion USD), 2025-2033
Figure 14: Europe: Specialty Generics Market (Other Routes of Administration): Sales Value (in Billion USD), 2019 & 2024
Figure 15: Europe: Specialty Generics Market (Other Routes of Administration) Forecast: Sales Value (in Billion USD), 2025-2033
Figure 16: Europe: Specialty Generics Market (Oncology): Sales Value (in Billion USD), 2019 & 2024
Figure 17: Europe: Specialty Generics Market (Oncology) Forecast: Sales Value (in Billion USD), 2025-2033
Figure 18: Europe: Specialty Generics Market (Autoimmune Diseases): Sales Value (in Billion USD), 2019 & 2024
Figure 19: Europe: Specialty Generics Market (Autoimmune Diseases) Forecast: Sales Value (in Billion USD), 2025-2033
Figure 20: Europe: Specialty Generics Market (Infectious Diseases): Sales Value (in Billion USD), 2019 & 2024
Figure 21: Europe: Specialty Generics Market (Infectious Diseases) Forecast: Sales Value (in Billion USD), 2025-2033
Figure 22: Europe: Specialty Generics Market (Other Indications): Sales Value (in Billion USD), 2019 & 2024
Figure 23: Europe: Specialty Generics Market (Other Indications) Forecast: Sales Value (in Billion USD), 2025-2033
Figure 24: Europe: Specialty Generics Market: Sales through Retail Pharmacies (in Billion USD), 2019 & 2024
Figure 25: Europe: Specialty Generics Market Forecast: Sales through Retail Pharmacies (in Billion USD), 2025-2033
Figure 26: Europe: Specialty Generics Market: Sales through Specialty Pharmacies (in Billion USD), 2019 & 2024
Figure 27: Europe: Specialty Generics Market Forecast: Sales through Specialty Pharmacies (in Billion USD), 2025-2033
Figure 28: Europe: Specialty Generics Market: Sales through Hospital Pharmacies (in Billion USD), 2019 & 2024
Figure 29: Europe: Specialty Generics Market Forecast: Sales through Hospital Pharmacies (in Billion USD), 2025-2033
Figure 30: Germany: Specialty Generics Market: Sales Value (in Billion USD), 2019 & 2024
Figure 31: Germany: Specialty Generics Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 32: United Kingdom: Specialty Generics Market: Sales Value (in Billion USD), 2019 & 2024
Figure 33: United Kingdom: Specialty Generics Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 34: France: Specialty Generics Market: Sales Value (in Billion USD), 2019 & 2024
Figure 35: France: Specialty Generics Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 36: Italy: Specialty Generics Market: Sales Value (in Billion USD), 2019 & 2024
Figure 37: Italy: Specialty Generics Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 38: Spain: Specialty Generics Market: Sales Value (in Billion USD), 2019 & 2024
Figure 39: Spain: Specialty Generics Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 40: Rest of Europe: Specialty Generics Market: Sales Value (in Billion USD), 2019 & 2024
Figure 41: Rest of Europe: Specialty Generics Market Forecast: Sales Value (in Billion USD), 2025-2033